A novel capecitabine dosing schedule combined with bevacizumab is safe and active in patients with metastatic breast cancer: A phase II study Meeting Abstract


Authors: Traina, T. A.; Theodoulou, M.; Dugan, U.; Feigin, K.; Patil, S.; Edwards, C.; Norton, L.; Hudis, C. A.
Abstract Title: A novel capecitabine dosing schedule combined with bevacizumab is safe and active in patients with metastatic breast cancer: A phase II study
Meeting Title: 44th Annual Meeting of the American Society of Clinical Oncology (ASCO)
Journal Title: Journal of Clinical Oncology
Volume: 26
Issue: 15 Suppl.
Meeting Dates: 2008 May 30-Jun 3
Meeting Location: Chicago, IL
ISSN: 0732-183X
Publisher: American Society of Clinical Oncology  
Date Published: 2008-05-20
Start Page: 66s
Language: English
ACCESSION: WOS:000208457400242
PROVIDER: wos
DOI: 10.1200/jco.2008.26.15_suppl.1101
Notes: Meeting Abstract: 1101 -- Source: Wos
Altmetric Score
MSK Authors
  1. Kimberly Nicole Feigin
    20 Feigin
  2. Sujata Patil
    386 Patil
  3. Clifford Hudis
    848 Hudis
  4. Larry Norton
    581 Norton
  5. Tiffany A Traina
    154 Traina